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Summary
Objective: The objectives of this study were to determine the sensitivity to change of magnetic resonance imaging (MRI) quantification of
chondropathy after 1 year in osteoarthritis of the medial tibiofemoral compartment and to assess the predictive value of subchondral bone
marrow edema and bone abnormalities on progression of chondropathy.
Design: Twenty patients with symptomatic knee osteoarthritis of the medial compartment underwent a prospective, longitudinal study. All
patients were evaluated the same day at entry and after 1 year by plain weight-bearing radiographs, MRI with a three-dimensional
gradient-echo sequence, using a 0.2-T dedicated MR unit, and arthroscopy. The medial tibiofemoral chondropathy was quantified blindly with
MRI and arthroscopy using the French Society of Arthroscopy (SFA) score. Presence of subchondral bone marrow edema and bone
abnormalities on initial MRI was recorded in order to evaluate their influence on both unchanged and worsened chondropathy after 1 year.
Results: After 1 year, no statistically significant changes were observed with plain radiographs and arthroscopy. At variance, a statistically
significant worsening of chondropathy was found with MRI using the SFA-MR score (P0.01). SFA-MR score was the most responsive
outcome. Absence of subchondral bone abnormalities and bone marrow edema on initial MR assessment predicted absence of worsening
of chondropathy after 1 year.
Conclusion: MRI appears promising for evaluating progression of knee osteoarthritis.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
Knee osteoarthritis (OA) is a major cause of pain and
disability1. Radiological variables are now widely used as
outcome measures to determine progression of osteo-
arthritis of the knee in clinical trials and to describe the
course of the disease in epidemiologic studies2,3. However,
both mild cartilage lesions, and severe and deep cartilage
erosions of the knee may remain undetected on weight-
bearing radiographs4–7. By using arthroscopy, a composite
index that takes into account not only location and depth of
cartilage lesions but also their extent was required in order
to follow and to quantify the evolution of chondropathy of
one compartment of the knee joint. Such a composite index
of severity of chondropathy was established by the French
Society of Arthroscopy (SFA) and is known as the SFA
scoring system8,9. Reliability, validity, clinical relevance,
and sensitivity to change of the arthroscopic SFA scoring
system have been validated in populations with mild8,9 and
with severe chondropathy7. In a preliminary study, quanti-
fication of chondropathy of the knee with MR imaging using
the SFA scoring system (called SFA-MR scoring system)
was shown to be feasible and well correlated with anatomic
cartilage breakdown detected by arthroscopy10. However,
the sensitivity to change of the SFA-MR score has not yet
been assessed.
Although degradation of articular cartilage is the main
feature of osteoarthritis, the subchondral bone is also in-
volved either prior to or subsequent to the appearance of
chondral alterations11–14. In a scintigraphy study using
technetium-labelled biphosphonate, a negative bone scan
proved to be a powerful negative predictive factor for the
development of joint space loss over the following 5 years11.
The purpose of our study was to determine the sensitivity
to change of the MR scoring system in a population of
symptomatic patients with medial tibiofemoral osteo-
arthritis, and to evaluate the ability of subchondral bone
marrow edema and bone signal abnormalities to predict
subsequent progression of osteoarthritis.
Materials and methods
PATIENTS
Twenty patients (13 women, 7 men; age range, 31–82
years; mean age, 63 years) were included in the study after
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providing informed consent. All patients were examined
by the same rheumatologist (XA), and had symptomatic
medial tibiofemoral osteoarthritis with indication for a joint
lavage by means of arthroscopy. They fulfilled the American
College of Rheumatology clinical and radiographic criteria
for knee osteoarthritis15. Other inclusion criteria were: (1)
clinical involvement (pain) of the medial tibiofemoral
compartment; (2) symptomatic disease (inadequate pain
control certified by prior failure of intraarticular glucocorti-
coid injection, physical exercises, analgesics, and non-
steroidal anti-inflammatory drugs); (3) mild radiographic
osteoarthritis of the medial compartment (medial tibio-
femoral joint space ≥2 mm on a weight-bearing extended
anteroposterior view), and (4) lack of contraindication for
MR imaging and arthroscopic procedures.
STUDY DESIGN
This single-center, prospective, longitudinal study was
approved by the ethics committee of our institution. Plain
films, MR imaging, and arthroscopy were performed the
same day at the initial time point and after 1 year.
CLINICAL CHARACTERISTICS
Demographic data and osteoarthritis variables were re-
corded for each patient. Demographic data included age,
sex, and body mass index. Baseline characteristics of knee
osteoarthritis included disease duration. Clinical activity of
osteoarthritis was assessed before MRI and arthroscopy
using the following variables: (1) pain, evaluated on a
100 mm visual analog scale (VAS)5 and by the Western
Ontario and Mac Master University (WOMAC) osteo-
arthritis index pain subscale16, which is a self-administered
health status instrument designed specifically for the
assessment of lower extremity pain and function in osteo-
arthritis of the knee or hip; (2) knee stiffness evaluated by
the WOMAC stiffness subscale; (3) functional disability,
evaluated by the WOMAC function subscale and by
Lequesne’s functional index17, which consists of 10 ques-
tions regarding the presence of pain or disability and
walking distance capacity, and (4) presence of knee
effusion.
RADIOGRAPHIC VARIABLES
Radiological evaluation consisted of bilateral antero-
posterior weight-bearing knee radiographs with the knee
fully extended, and bilateral posteroanterior weight-bearing
knee radiographs in flexed position. Radiographs were
taken with patients standing on both legs, in a single
radiography unit by a staff of three technicians using a
standardized technique: cassette placed posterior or an-
terior to the knee for extended or flexed radiographs,
respectively, X-ray beam centered on joint space and
inclined to be parallel to the medial tibial plateau with the
aid of fluoroscopy, with a tube to film distance of 110 cm.
The position of the feet and the angle of flexion and the
angle of the X-ray beam were noted and verified for the
radiologic evaluation at the 1 year follow-up18. The severity
of osteoarthritis of the medial tibiofemoral compartment
was evaluated using the Kellgren and Lawrence grading
system19, and by measuring the joint space width in
millimeters along a vertical line at the narrowest point of the
medial compartment using a graduated magnifying glass9.
The paired radiographs of each patient at entry and after 1
year were read by one investigator (PR) using a blind
procedure in which the investigator was unaware of patient
identity and chronology of the radiographs.
MR DATA COLLECTION
Patients underwent MR imaging with a 0.2 T musculo-
skeletal dedicated MR unit (Artoscan; Esaote Biomedica,
Genoa, Italy). Knees were placed in a receive-only, cylin-
dric solenoid coil. Two successive three-dimensional
gradient-echo sequences (repetition time (ms)/echo time
(ms), 60/24; 45° flip angle) were acquired in the sagittal and
coronal planes with, respectively, 40 and 32 contiguous
1.4 mm-thick sections (Fig. 1). The field of view was
150 mm, the matrix 192×160, and voxels were anisotopic
with a size of 0.78×0.94×1.4 mm3. The acquisition time of
each sequence ranged from 5 min 9 s to 6 min 26 s, with
one signal acquired. A T2-weighted two-dimensional
gradient-echo sequence (TR/TE: 650/16 ms; 35° flip angle)
was acquired in the coronal plane with 15 contiguous
4 mm-thick sections. The field of view was 160 mm, the
matrix 192×160, the acquisition time was 3 min 32 s, with
two signals acquired. A T1-weighted spin-echo (TR/TE:
520/15 ms) was acquired in the coronal plane with 15
contiguous 4 mm-thick sections. The field of view was
160 mm, the matrix 192×160, the acquisition time was
3 min 20 s, with two signals acquired.
ARTHROSCOPIC DATA COLLECTION
The arthroscopic exploration was performed immediately
after MR imaging, and focused on the medial tibiofemoral
compartment. Arthroscopy was performed by a trained
arthroscopist (XA) with use of local anesthesia with epine-
phrine, without tourniquet hemostasis. A 2.7-mm Storz
arthroscope (Storz, Paris, France) with a 30° angled view
was used in an inferolateral approach. The medial femoral
condyle was explored from 0 to 90° of knee flexion in order
to assess cartilage status of its posterior part. The anterior
limit of the condyle was defined by the anterior limit of
the roof of the intercondylar notch. Each arthroscopic
exploration was recorded on videotape.
Fig. 1. Sagittal three-dimensional gradient-echo 1.4 mm thick
images (60/24, 45° flip angle) shows no cartilage defect (grade 0)
of the medial tibiofemoral compartment.
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ARTHROSCOPIC DATA EVALUATION
Qualitative study
The severity of cartilage breakdown was studied for the
medial condyle and medial tibial plateau. The depth of
cartilage abnormalities was graded 0–IV according to the
classification proposed by Beguin and Locker20: grade 0,
normal cartilage; grade I, swelling and/or softening; grade
II, superficial fibrillations; grade III, deep fibrillations
down to bone or deep erosions; grade IV, exposure of
subchondral bone.
Quantitative study
The first step consisted in recording on an articular
diagram of the knee (Fig. 2) the observed chondropathy
with three main baseline variables10: (1) location: medial
femur, and medial tibia; (2) depth based on the classifi-
cation of chondropathy proposed by Beguin and
Locker10,20; and (3) size. The size of the lesions was
estimated by the arthroscopist as a percentage (from 0 to
100%) of the entire articular surface and was recorded on a
special form5,8. The SFA score is a composite index of
severity of chondropathy taking into account location,
depth, and size of cartilage lesions. This score is a continu-
ous variable between 0 and 100 obtained from the medial
tibiofemoral compartment as follows9,10: SFA score=
SI×0.14+SII×0.34+SIII×0.65+SIV×1.00, where SI through
SIV are the size (expressed as percentage) of grade I–IV
lesions. The size (as a percentage) of grade X (where X is
0–IV) corresponds to the mean value of the size of grade X
of the medial femoral condyle and the medial tibial plateau.
In this study, the SFA score obtained arthroscopically was
called the SFA-arthroscopic score. The paired arthroscopic
videotapes of each patient at entry and after 1 year were
read by one investigator (XA), using a blind procedure in
which the investigator was unaware of patient identity and
unaware of the chronology of the arthroscopic videotapes.
The mean time required for paired reading of one patient’s
paired videotapes was 45 min.
MR IMAGING DATA EVALUATION
Articular cartilage lesions
Qualitative study. The severity of cartilage lesions was also
noted for each articular surface of the medial tibio-
femoral compartment. The limits of the condyles were
defined to match with the arthroscopic field of investigation:
the anterior limit was defined by the anterior limit of the roof
of the intercondylar notch10 and the posterior limit was the
posterior end of the condylar cartilage. The depth of carti-
lage abnormalities were graded 0–IV (MR grade), derived
from the arthroscopic classification of Beguin and
Locker10,20 (Fig. 2).
Quantitative study. The SFA-MRI scoring system was
derived from the SFA-arthroscopic scoring system. As with
arthroscopy, the observed chondropathy was reported on a
similar articular diagram of the knee using sagittal and
coronal slices10 (Fig. 2). The SFA-MR score was calculated
using the mathematical formula described for arthroscopy
and taking into account the depth of chondral lesions, seen
on MR images, and their size. The paired MR investi-
gations of each patient at entry and after 1 year were
analyzed by one investigator (EP), using a blind procedure
in which the investigator was unaware of patient identity
and unaware of the chronology of the MR examinations.
The mean time required for paired reading of one patient’s
MRI was half an hour.
Bone marrow edema. Subchondral edema was defined as
diffuse and ill-defined areas with intermediate-low signal
on T1-weighted images and high signal on T2-weighted
images (Fig. 3), and was recorded for each medial tibio-
femoral compartment.
Subchondral bone abnormalities. Subchondral bone cyst
and sclerosis were defined as circumscribed areas with low
signal on T1-weighted images and respectively very high or
low signal intensity on T2-weighted images, and were
Fig. 2. Example of knee diagram for recording location, depth and extent of articular cartilage lesions of the medial tibiofemoral compartment
(right knee) with arthroscopy and MRI. III and IV are grades depth of chondral lesions including: grade 0, normal cartilage; grade I, swelling
and/or softening at arthroscopy, focal blistering and intracartilaginous low signal intensity area at MRI; grade II, superficial fibrillations at
arthroscopy, superficial irregularities and loss of thickness of less than 50% at MRI; grade III, deep fibrillations or erosions at arthroscopy,
deep ulceration with loss of thickness of more than 50% at MRI; grade IV, exposure of subchondral bone.
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recorded for each articular surface of the medial tibio-
femoral compartment (Fig. 4).
Statistical analysis
Sensitivity to change. Sensitivity to change was evaluated
by comparing severity of chondropathy with plain films,
MRI, and arthroscopy in the same patient at entry and after
1 year of follow-up. To detect changes with continuous
variables (joint space width, SFA-MR score and SFA-
arthroscopic score), we used the Wilcoxon signed rank test
to compare values observed at Day 0 and after 1 year, and
the standardized response to mean (SRM), calculated as
the mean change between 1 year and baseline divided by
the standard deviation of the change21. A high SRM indi-
cates high sensitivity to change. For all variables, patients
were categorized into those having no change and those
who had improved or worsened after 1 year (categorical
variables). Based on the results of intraobserver reliability
of the arthroscopic and MR quantification of chondropa-
thy7,10, the changes observed in both the SFA-arthroscopic
score and SFA-MR score were switched to a categorical
variable considered as related to disease evolution and not
related to the variability of measurement: improvement was
defined by a change (Day 365−Day 0) ≤4.5 and ≤12,
worsening by a change >4.5 and >12 for the SFA-
arthroscopic score7 and the SFA-MR score10, respectively.
To detect changes with categorical variables, we used the
chi-squared test.
Bone marrow edema and subchondral bone study. Vari-
ation of the SFA-MR score after the 1 year follow-up was
studied for the knees with and without bone marrow edema
or subchondral bone abnormalities on MRI at entry. Based
on the results of intraobserver reliability of the SFA-MR
score10, the SFA-MR score was switched into a categorical
variable (unchanged or worsened). The presence of bone
marrow edema or subchondral bone abnormalities on
initial MR imaging was compared for both unchanged and
worsened chondropathy after 1 year.
Results
PATIENT CHARACTERISTICS
The clinical and radiographic characteristics of the
patients at entry are summarized in Table I
SENSITIVITY TO CHANGE
The changes in chondropathy of the medial compartment
evaluated by plain films, MRI and arthroscopy after 1 year
Fig. 3. Subchondral edema within medial femoral condyle. Gradi-
ent echo MR image (TR/TE: 650/16 ms; 35° flip angle) show an
ill-defined area in the underlying subchondral bone (between
arrows) with low signal on T1 (not showned) and high signal on
T2-weighted image.
Fig. 4. Sagittal three-dimensional gradient-echo 1.4 mm thick
image (60/24, 45° flip angle) shows subchondral cyst within medial
femoral condyle and medial tibial plateau (arrows).
Table I
Characteristics of the patients
Variables Total (n20)
Demographic data
Age (years) 63±9
Sex (M/F) 7/13
Body mass index 30±5
Baseline characteristics
Knee (right/left) 14/6
Disease duration (years) 5±3
Clinical activity
Pain (100 mm VAS) 49±16
WOMAC pain (0–4) 2.1±0.6
WOMAC stiffness (0–4) 2.3±0.8
WOMAC function (0–4) 2.0±0.7
Lequesne functional index 9.2±3.5
Knee effusion (yes/no) 8/12
Radiological severity (Kellgren and Lawrence
grading)
O 0
I 0
II 7
III 13
IV 0
BMI, body mass index=weight(kg)/[height(m)]2; VAS, visual ana-
log scale; WOMAC, Western Ontario and Mac Master University
osteoarthritis index.
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follow-up are summarized in Table II. No statistically signifi-
cant changes were observed with plain radiographs and
arthroscopy by using continuous variables or categorical
variables. At variance, a statistically significant worsening
of chondropathy was found with MR imaging using the
SFA-MR score as a continuous variable (p=0.01). Changes
of the SFA-MR score switched to a categorical variable
were not statistically significant. The continuous SFA-MR
score was the most responsive outcome (SRM=1), con-
trasting with a smaller SRM of the SFA-arthroscopic
scoring system (0.25), and a minimum SRM of joint space
width measurement (0.1).
SUBCHONDRAL BONE ABNORMALITIES AND BONE MARROW
EDEMA
Correlations between subchondral bone abnormalities
and bone marrow edema at entry, and deterioration of the
cartilage of the medial tibiofemoral compartment after 1
year are summarized in Tables III and IV. For one patient,
the presence of artifact prevented the analysis of bone
marrow edema (total number of evaluated patients=19).
Using the SFA-MR score as a continuous variable, the
presence of subchondral bone abnormalities at baseline
was correlated with a statistically greater worsening of
chondropathy after 1 year (Table III). Using the SFA-MR
score as a categorical variable (worsened, unchanged),
none of the knees without subchondral signal abnormalities
or bone marrow edema worsened. The negative predictive
value of bone marrow edema or subchondral bone signal
abnormalities on MR at entry was 100%. At variance,
presence of bone marrow edema was associated with
worsening of chondropathy (P0.06). The positive predic-
tive value was 23% for subchondral bone abnormalities
(cyst, osteosclerosis) and 40% for bone marrow edema. No
additional subchondral bone abnormalities and bone
Table II
Sensitivity to change of radiographic, MRI and arthroscopic evaluation of chondropathy of the medial tibiofemoral compartment after 1 year
follow-up (n20)
At entry After 1 year Change
Continuous variable Continuous variable switched to a categorical
variable
∆ P* SRM Improved
[n (%)]
Unchanged
[n (%)]
Worsened
[n (%)]
p**
Radiology
Joint space width (mm)
Extension 3.8±1.1 3.8±1.8 −0.1±0.9 >0.05 0.1 0 20 (100) 0 >0.05
Flexed position 2.8±1.7 2.8±1.9 0.0±0.6 >0.05 0 0 20 (100) 0 >0.05
MR imaging
SFA-MR score 16.3±14.7 22.0±15.6 5.7±5.5 0.01 1.0 0 17 (85) 3 (15) >0.05
Arthroscopy
SFA-arthroscopic score 40.8±17.8 41.8±18.4 1.0±4.0 >0.05 0.25 1 (5) 17 (85) 2 (10) >0.05
∆, change after 1 year follow-up (Day 365−Day 0); *, Wilcoxon signed rank test; **, chi-squared test; SRM, standardized response to mean
calculated as the mean change between 1 year and baseline divided by the standard deviation of the change.
Table III
Correlation between subchondral signal abnormalities (cysts and sclerosis) at entry and deterioration of the cartilage of the medial
tibiofemoral compartment after 1 year follow-up (MRI evaluation, n20)
MRI change after 1 year Subchondral abnormalities (medial tibiofemo-
ral plateau)
P
Absent (n7) Present (n13)
∆ SFA-MR score (continuous variable) 2.0±1.8 7.8±5.8 0.05*
∆ SFA-MR score (continuous variable switched to a categorical variable) Worsened: 0 Worsened: 3 0.25**
Unchanged: 7 Unchanged: 10
*Mann–Whitney U test; **Fisher test.
Table IV
Correlation between bone marrow edema at entry and deterioration of the cartilage of the medial tibiofemoral compartment after 1 year
follow-up (MRI evaluation, n19)
MRI change after 1 year Bone marrow edema (medial tibiofemoral
plateau)
P
Absent (n14) Present (n5)
∆ SFA-MR score (continuous variable) 3.8±3.6 10.1±7.4 >0.1*
∆ SFA-MR score (continuous variable switched to a categorical variable) Worsened: 0 Worsened: 2 0.06**
Unchanged: 14 Unchanged: 3
*Mann–Whitney U test; **Fisher test.
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marrow edema develop after 1 year. Bone marrow edema
of the medial tibial plateau disappeared in two patients.
In these two patients, the SFA-MR score and the SFA-
arthroscopic score was unchanged after 1 year.
Discussion
The selected method to assess osteoarthritis of the knee
must fulfill the following characteristics: simplicity, validity,
reliability, and sensitivity to change22. Our preliminary study
showed that MRI fulfills the first three criteria10. This pilot
study suggests that quantification of chondropathy by MRI
might be sensitive enough to detect changes within a short
period of time (1 year). Sensitivity to change in cartilage
breakdown is difficult to demonstrate. After 1 year, no
statistically significant changes in radiological and arthro-
scopic parameters were observed in this study, contrasting
with a statistically significant worsening of the SFA-MR
score. The absence of significant change for the joint space
width measurement after 1 year is consistent with the study
of Ravaud et al.23. Variability in radiographic procedure or
in joint positioning may induce modification of joint space
width measurements18. However, in our study the radio-
graphic technique was standardized and the position of the
feet was verified, as proposed by Buckland-Wright24. Two
previous studies performed in the same arthroscopic center
and using SFA-arthroscopic scoring system, found in 41
patients7 and in 17 patients25 suffering from medial knee
osteoarthritis, a statistically significant worsening of chon-
dropathy after 1 year follow-up. In the present study with 20
patients, we did not find a significant change for this
arthroscopic scoring. This discrepancy could be explained
by the main limitation of this study, which is its small sample
size.
At variance, in the present study we found a significant
worsening of the SFA-MR score after 1 year follow-up.
However, the level of significance of a mean change is not
in itself a measure of the size of the effect, and the
detection of statistically significant changes does not imply
that such changes are clinically meaningful26. On the other
hand, changes may be clinically important and relevant but
not statistically significant if the sample studied is too small.
The SRM indicates the magnitude of change independent
of the sample size. Another advantage of SRM is to
translate change in various measures into a unit-free nu-
merical quantity, which facilitates comparison between
these measures26. According to SRM, SFA-MR score
seems the most responsive outcome after 1 year follow-up.
This result may be explained by the different means used to
explore cartilage with MRI and arthroscopy. With MRI, the
whole articular surface can easily be investigated with films
placed side by side on double view boxes. Reviewing
arthroscopy paired videotapes is more time consuming,
and detecting small changes in location, depth and size of
the chondral surface over time may be more difficult. A
quantitative approach to the articular cartilage by focusing
on measurements of the volume cartilage27–30 may be
more reproducible but need a dedicated three-dimensional
workstation or custom software27,31 which is not necessary
with our global semiquantitative assessment of the carti-
lage. Moreover, volumetric quantification with three-
dimensional reconstruction may be less sensitive than
single-section data of the SFA-MR method in identifying
tiny focal defects in the cartilage. For this reason, semi-
quantitative scoring methods may be more reliable for
longitudinal evaluation of focal chondral defects than are
volume measurements.
Previous studies implicated the subchondral bone in
exacerbating the degeneration of the cartilage11–14. Radin
and Rose proposed that increases in the stiffness of the
underlying bone was associated with cartilage degener-
ation14. A healthy joint assists in high load tolerance by
deformation and microfractures within the tissue, thus en-
suring that energy is dissipated. When subchondral bone
thickens, the shock-absorbing capacity of the bone is
drastically reduced and shear stress increases between the
bone–cartilage interface due to increase of bone stiffness.
It was suggested that these bone morphological changes
culminate in cartilage fibrillation and subsequent joint de-
generation14,32. In this study, absence of subchondral bone
abnormalities and bone marrow edema on MRI at entry
was predictive of no deterioration of chondropathy after 1
year. This high negative predictive value (100%) supports a
scintigraphy study11 using technetium-labelled biphospho-
nate. They reported that cartilage lesions do not progress
significantly on standing weight-bearing radiographs over
the ensuing 5 years in the absence of a concomitant
increased activity of the bone at entry11. Conversely in our
study, presence of subchondral bone abnormalities and
bone marrow edema on MRI at entry was associated with
deterioration of cartilage in, respectively, 23 and 40% of the
patients.
The relation between articular cartilage degradation and
bone marrow edema is not clear. In a recent study33, bone
marrow lesions were found in 272 of 351 (77.5%) patients
with painful knees related to osteoarthritis. This proportion
is no so high with our study (five of 19 patients with
symptomatic medial tibiofemoral compartment knee osteo-
arthritis). This discrepancy can be explained by the small
sample of the present study. In this study, bone marrow
edema (n5) was always associated with subchondral
cyst or sclerosis (n13). At variance, subchondral cyst or
sclerosis could be present without bone marrow edema (in
eight patients over 13). Bone marrow edema and subchon-
dral cyst or sclerosis were always located under cartilage
lesions. The size of the bone marrow edema is widely
variable with the sequence used and with the strength field
of the MR unit34. For this reason, size of the bone marrow
edema was not measured in the present study, and its
correlation with the extent of chondropathy at baseline and
1 year later was not evaluated. A recent study suggests that
necrotic bone marrow cells contribute more than edema to
these diffuse and ill-defined areas of low signal on T1-
weighted images and high signal on T2-weighted images35.
Whatever may the case, this feature, hypothetically consid-
ered to represent bone edema, is typical, easy to recog-
nize, is most likely to reflect bone activity, is strongly
associated with the presence of pain in knee osteoarthri-
tis33, and our study indicates that progression of osteo-
arthritis is unlikely in the absence of this so-called bone
marrow edema and emphasizes the potential importance of
subchondral bone in osteoarthritis. Since the purpose of
this work was to evaluate the sensitivity to change and the
ability to predict progression of osteoarthritis with MRI, we
did not correlate the clinical parameters and their change at
1 year with plain films, arthroscopy and MR data.
Several limitations of this pilot study must be noted. First,
these results are based on a small sample and need to be
confirmed in a large sample. Second, the use of a low-field
magnet (0.2 T), which is considered to give inferior image
quality is a potential limitation. Moreover, fat suppression,
which has been used by most authors to quantify
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cartilage is not available at low field strength, the fat and
water peaks being too close. However, cartilage appeared
spontaneously with a high signal intensity at 0.2 T, and
there was high contrast between the cartilage and the
subchondral bone and the surrounding soft tissues (Fig. 1).
With high field strength, fat suppression is useful to elimi-
nate chemical shift artifacts such as the interface between
the cartilage and the subchondral bone. These artifacts are
minimized with low-field-strength MR units. Moreover, pre-
vious studies have shown that cartilaginous lesions can
be evaluated reliably with low-field-strength in patella of
cadavers36 and in patients with symptomatic osteoarthritis
of the tibiofemoral joint10.
Third, with 1.5 T magnets, fast spin echo T2 fat sat
images and STIR are much more reliable than T1 or GRE
T2* images for showing bone marrow edema. Since at
0.2 T, fat suppression is not possible, we used SE T1 and
GRE T2* sequences; this could have an effect on the value
of bone marrow edema to predict subsequent progression
of osteoarthritis. However, gradient-echo images are in-
sensitive to marrow abnormalities at 1.5 T because of large
differences in magnetic susceptibility between trabecular
bone and adjacent marrow tissue at high-field strength34.
This is not the case, however, with low-field MR imaging. At
0.2 T, because of decreased magnetic susceptibility effects,
T2-weighted gradient echo imaging offers high contrast-to-
noise ratio between water and fat in the marrow cavity34.
Fourth, since there are difficulties in repositioning the
patient for imaging, a single slice [Fig. 5(A,B)] could well not
correspond to precisely the same area in the medial
compartment. Two successive MR image sequences on
the same day after the patient was taken out of the magnet
and repositioned, to determine any significant difference in
the SFA-MR score, was not performed. However, in this
study, we did not compare slice by slice the thickness of the
cartilage with two sets of imaging, since we compared an
overall quantitative assessment of the entire articular sur-
face of the medial tibiofemoral compartment. Results of
thickness measurement are not reproducible without a
position marker to identify the same location on the carti-
lage. Conversely, the position of the knee in the magnet
does not interfere with the overall assessment of the entire
articular cartilage.
Fifth, we tried to match the anterior limit of the condylar
areas explored with MRI and arthroscopy, but the posterior
edge of the condyle and the peripheral area of the tibial
plateau below the medial meniscus were not always attain-
able by the arthroscopist. Therefore the area investigated
with MR imaging was larger than that visible at arthroscopy,
which decreased systematically the SFA-MR score. This is
consistent with a preliminary study, which found the
SFA-MR scores lower than the SFA-arthroscopic scores10.
However, the same study showed a statistically significant
Fig. 5. Three-dimensional gradient-echo 1.4 mm thick images
(60/24, 45° flip angle) of the medial tibiofemoral compartment at
baseline and after 1 year follow-up. (A) Sagittal view at baseline
shows a deep ulceration (grade III) of the femoral condyle (be-
tween arrows) with a well-defined low signal intensity area in the
underlying subchondral bone (open arrow). (B) Sagittal view at
baseline slightly medial to level A shows a deep ulceration (grade
III) of the femoral condyle (between white arrows) with an ill-
defined low-signal-intensity area in the underlying subchondral
bone (black curved arrow). (C) Sagittal view after 1 year follow-up
shows a deeper ulceration (grade IV) of the femoral condyle
(between white arrows). Note the cartilage of the tibial plateau
(arrowhead).
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correlation between the SFA-MR and SFA-arthroscopic
scores10.
In conclusion, this pilot study suggests that quantification
of chondropathy by MRI might be sensitive enough to
detect changes within a relatively short period of time, by
using the SFA-MR scoring system. If these findings are
confirmed, SFA-MRI scoring could be used as an outcome
measure of cartilage lesions in clinical trials aimed to
evaluate potential structure modifying drugs in osteoarthri-
tis. Moreover, the presence of subchondral bone abnor-
malities and bone marrow edema may be used in
prospective clinical trials as inclusion criteria in order to
evaluate patients with potentially active osteoarthritis,
which is particularly adapted for testing potential chondro-
protective drugs. In daily practice, when MRI is required in
knee osteoarthritis, the absence of bone marrow edema or
subchondral abnormalities on MRI could indicate for the
clinician that the chondral disorder is unlikely to progress
over the next year. The clinical relevance of these findings
remains to be assessed. Further longitudinal studies with a
larger sample are required to confirm these results.
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